Myocarditis in COVID-19 patients: current problems

Myocarditis has been reported as a possible clinical presentation or complication in patients with coronavirus disease (COVID)-19 due to SARS-CoV-2. Despite the alarm that this possibility generated among physicians, there is paucity of information about mechanisms, prevalence, prognosis, diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mele, Donato, Flamigni, Filippo, Rapezzi, Claudio, Ferrari, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Im - Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823176/
https://www.ncbi.nlm.nih.gov/pubmed/33484452
http://dx.doi.org/10.1007/s11739-021-02635-w
_version_ 1783639779084075008
author Mele, Donato
Flamigni, Filippo
Rapezzi, Claudio
Ferrari, Roberto
author_facet Mele, Donato
Flamigni, Filippo
Rapezzi, Claudio
Ferrari, Roberto
author_sort Mele, Donato
collection PubMed
description Myocarditis has been reported as a possible clinical presentation or complication in patients with coronavirus disease (COVID)-19 due to SARS-CoV-2. Despite the alarm that this possibility generated among physicians, there is paucity of information about mechanisms, prevalence, prognosis, diagnosis and therapy of myocarditis in the context of COVID-19. This brief review has the goal to revise and summarize current knowledge on myocarditis in COVID-19 patients and underline problems especially related to diagnosis and treatment.
format Online
Article
Text
id pubmed-7823176
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-78231762021-01-25 Myocarditis in COVID-19 patients: current problems Mele, Donato Flamigni, Filippo Rapezzi, Claudio Ferrari, Roberto Intern Emerg Med Im - Review Myocarditis has been reported as a possible clinical presentation or complication in patients with coronavirus disease (COVID)-19 due to SARS-CoV-2. Despite the alarm that this possibility generated among physicians, there is paucity of information about mechanisms, prevalence, prognosis, diagnosis and therapy of myocarditis in the context of COVID-19. This brief review has the goal to revise and summarize current knowledge on myocarditis in COVID-19 patients and underline problems especially related to diagnosis and treatment. Springer International Publishing 2021-01-23 2021 /pmc/articles/PMC7823176/ /pubmed/33484452 http://dx.doi.org/10.1007/s11739-021-02635-w Text en © Società Italiana di Medicina Interna (SIMI) 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Im - Review
Mele, Donato
Flamigni, Filippo
Rapezzi, Claudio
Ferrari, Roberto
Myocarditis in COVID-19 patients: current problems
title Myocarditis in COVID-19 patients: current problems
title_full Myocarditis in COVID-19 patients: current problems
title_fullStr Myocarditis in COVID-19 patients: current problems
title_full_unstemmed Myocarditis in COVID-19 patients: current problems
title_short Myocarditis in COVID-19 patients: current problems
title_sort myocarditis in covid-19 patients: current problems
topic Im - Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823176/
https://www.ncbi.nlm.nih.gov/pubmed/33484452
http://dx.doi.org/10.1007/s11739-021-02635-w
work_keys_str_mv AT meledonato myocarditisincovid19patientscurrentproblems
AT flamignifilippo myocarditisincovid19patientscurrentproblems
AT rapezziclaudio myocarditisincovid19patientscurrentproblems
AT ferrariroberto myocarditisincovid19patientscurrentproblems

Ejemplares similares